335 related articles for article (PubMed ID: 27015221)
21. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and pattern of antiphospholipid antibody syndrome in a hospital based longitudinal study of 193 patients of systemic lupus erythematosus.
Singh NK; Agrawal A; Singh MN; Kumar V; Godhra M; Gupta A; Yadav DP; Usha ; Singh RG; Singh TB
J Assoc Physicians India; 2013 Sep; 61(9):623-6. PubMed ID: 24772699
[TBL] [Abstract][Full Text] [Related]
23. Acute left main coronary artery thrombosis as the first manifestation of systemic lupus erythematosus and catastrophic antiphospholipid syndrome.
González-Pacheco H; Eid-Lidt G; Piña-Reyna Y; Amezcua-Guerra LM; Aldana-Sepúlveda N; Martínez-Sánchez C
Am J Emerg Med; 2014 Feb; 32(2):197.e3-5. PubMed ID: 24176588
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of a multidisciplinary clinical pathway for women with systemic lupus erythematosus and/or antiphospholipid syndrome.
Wind M; Hendriks M; van Brussel BTJ; Eikenboom J; Allaart CF; Lamb HJ; Siebelink HJ; Ninaber MK; van Geloven N; van Lith JMM; Huizinga TWJ; Rabelink TJ; Sueters M; Teng YKO
Lupus Sci Med; 2021 May; 8(1):. PubMed ID: 33952625
[TBL] [Abstract][Full Text] [Related]
25. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus.
Tarr T; Lakos G; Bhattoa HP; Szegedi G; Shoenfeld Y; Kiss E
Lupus; 2007; 16(5):324-8. PubMed ID: 17576733
[TBL] [Abstract][Full Text] [Related]
26. Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case-control study over 10 years.
Ajeganova S; Hafström I; Frostegård J
Lupus Sci Med; 2021 Feb; 8(1):. PubMed ID: 33547230
[TBL] [Abstract][Full Text] [Related]
27. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
Cabiedes J; Cabral AR; Alarcón-Segovia D
J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
[TBL] [Abstract][Full Text] [Related]
28. Atherosclerosis progression in antiphospholipid syndrome is comparable to diabetes mellitus: a 3 year prospective study.
Evangelatos G; Kravvariti E; Konstantonis G; Tentolouris N; Sfikakis PP; Tektonidou MG
Rheumatology (Oxford); 2022 Aug; 61(8):3408-3413. PubMed ID: 34850863
[TBL] [Abstract][Full Text] [Related]
29. The interplay between the antiphospholipid syndrome and systemic lupus erythematosus.
Tincani A; Andreoli L; Chighizola C; Meroni PL
Autoimmunity; 2009 May; 42(4):257-9. PubMed ID: 19811269
[TBL] [Abstract][Full Text] [Related]
30. Adrenal insufficiency in systematic lupus erythematosus (SLE) and antiphospholipid syndrome (APS): A systematic review.
Lee KH; Lee H; Lee CH; Kim JY; Kim JM; Kim SS; Jeong S; Hwang IS; Kim N; Kim NE; Shin S; Shin D; Song JS; Shin DH; Kim JD; Kim J; Lee YS; Kang H; Kim DH; Moon SH; Rho WS; Lee JY; Kronbichler A; Shin JI
Autoimmun Rev; 2019 Jan; 18(1):1-8. PubMed ID: 30408580
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients.
Vianna JL; Khamashta MA; Ordi-Ros J; Font J; Cervera R; Lopez-Soto A; Tolosa C; Franz J; Selva A; Ingelmo M
Am J Med; 1994 Jan; 96(1):3-9. PubMed ID: 8304360
[TBL] [Abstract][Full Text] [Related]
32. Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome.
Jiménez S; García-Criado MA; Tàssies D; Reverter JC; Cervera R; Gilabert MR; Zambón D; Ros E; Bru C; Font J
Rheumatology (Oxford); 2005 Jun; 44(6):756-61. PubMed ID: 15757967
[TBL] [Abstract][Full Text] [Related]
33. [Significance of antiphospholipid syndrome and antiphospholipid antibodies in patients with systemic lupus erythematosus in estimation of risk of subclinical atherosclerosis development].
Fischer K; Brzosko M; Walecka A; Ostanek L; Sawicki M
Pol Arch Med Wewn; 2007; 117 Suppl():13-7. PubMed ID: 18778013
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
35. Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study.
Vlachoyiannopoulos PG; Kanellopoulos PG; Ioannidis JP; Tektonidou MG; Mastorakou I; Moutsopoulos HM
Rheumatology (Oxford); 2003 May; 42(5):645-51. PubMed ID: 12709540
[TBL] [Abstract][Full Text] [Related]
36. The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes.
Nalli C; Iodice A; Andreoli L; Lojacono A; Motta M; Fazzi E; Tincani A
Lupus; 2014 May; 23(6):507-17. PubMed ID: 24763535
[TBL] [Abstract][Full Text] [Related]
37. Evolution of cardiac dysfunction in patients with antiphospholipid antibodies and/or antiphospholipid syndrome: a 10-year follow-up study.
Kampolis C; Tektonidou M; Moyssakis I; Tzelepis GE; Moutsopoulos H; Vlachoyiannopoulos PG
Semin Arthritis Rheum; 2014 Feb; 43(4):558-65. PubMed ID: 24012042
[TBL] [Abstract][Full Text] [Related]
38. Adverse cardiovascular outcomes between insulin-treated and non-insulin treated diabetic patients after percutaneous coronary intervention: a systematic review and meta-analysis.
Bundhun PK; Li N; Chen MH
Cardiovasc Diabetol; 2015 Oct; 14():135. PubMed ID: 26446829
[TBL] [Abstract][Full Text] [Related]
39. Ocular retinal findings in asymptomatic patients with antiphospholipid syndrome secondary to systemic lupus erythematosus.
Neto EDS; Neto TSR; Signorelli F; Balbi GGM; Higashi AH; Monteiro MLR; Bonfá E; Andrade DCO; Zacharias LC
Clin Rheumatol; 2023 Aug; 42(8):2105-2114. PubMed ID: 37126136
[TBL] [Abstract][Full Text] [Related]
40. Biochemical and clinical predictors in pregnant women with antiphospholipid syndrome and systemic lupus erythematosus: comprehensive update.
Li X; Shopit A; Wang J
Arch Gynecol Obstet; 2021 Nov; 304(5):1153-1160. PubMed ID: 34390384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
